Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Rifampicin 450mg
sanofi-aventis new zealand limited
Rifampicin 450 mg
450 mg
Tablet
Active: Rifampicin 450mg
Bottle, glass, 1x30, 30 tablets
Prescription
Prescription
sanofi-aventis SpA
Package - Contents - Shelf Life: Bottle, glass, 1x30 - 30 tablets - 48 months from date of manufacture stored at or below 25°C
1969-12-31
Rifadin® ORAL 1 RIFADIN ® ORAL CONSUMER MEDICINE INFORMATION (CMI) SUMMARY The full CMI on the next page has more details. If you are worried about taking this medicine, speak to your doctor or pharmacist. 1. WHY AM I TAKING RIFADIN? Rifadin contains the active ingredient rifampicin. Rifadin is an antibiotic taken with other medicines to treat tuberculosis and is taken to treat leprosy. It is also taken to prevent meningococcal disease and infections caused by _Haemophilus Influenza_ Type B. For more information, see Section 1. Why am I taking Rifadin? in the full CMI. 2. WHAT SHOULD I KNOW BEFORE I TAKE RIFADIN? Do not take Rifadin if you have ever had an allergic reaction to Rifadin or any of the ingredients listed at the end of the CMI. Do not take Rifadin if you have jaundice. Do not take Rifadin if you are taking saquinavir or ritonavir. These are medicines used to treat AIDS and HIV. TALK TO YOUR DOCTOR IF YOU HAVE ANY OTHER MEDICAL CONDITIONS, TAKE ANY OTHER MEDICINES, OR ARE PREGNANT OR PLAN TO BECOME PREGNANT OR ARE BREASTFEEDING OR PLANNING TO BREASTFEED. For more information, see Section 2. What should I know before I take Rifadin? in the full CMI. 3. WHAT IF I AM TAKING OTHER MEDICINES? Some medicines may interfere with Rifadin and affect how it works. A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI. 4. HOW DO I TAKE RIFADIN? Follow the instructions provided when Rifadin was prescribed, including the number of days it should be taken. More instructions can be found in Section 4. How do I take Rifadin? in the full CMI. 5. WHAT SHOULD I KNOW WHILE TAKING RIFADIN? THINGS YOU SHOULD DO • Remind any doctor, dentist, surgeon, or pharmacist you visit that you are taking Rifadin. • You should see your doctor monthly for a check-up. • Continue taking Rifadin exactly as prescribed by your doctor. • If you have a blood or urine test, tell your doctor you are taking Rifadin. • If you are about to be started on a new medicine, including oral contraceptive Read the complete document
rifadin-ccdsv17-dsv20-20jun22 Page 1 NEW ZEALAND DATA SHEET 1 RIFADIN 150 MG, 300 MG CAPSULES, 100 MG/5ML SYRUP, AND 600 MG INFUSION Rifadin 150 mg capsules Rifadin 300 mg capsules Rifadin 100 mg/5 mL syrup Rifadin IV 600 mg infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Rifadin 150 mg and 300 mg capsules contain 150 mg and 300 mg of rifampicin per capsule respectively. Rifadin syrup contains 100 mg of rifampicin per 5 mL of syrup. Rifadin IV infusion contains 600 mg rifampicin per vial. Excipients with known effect: Capsules: contain sulfites. Syrup: Methyl hydroxybenzoate, propyl hydroxybenzoate, potassium sorbate, saccharin, sodium metabisulfite. For the full list of excipients, see section 6.1 List of Excipients. 3 PHARMACEUTICAL FORM Capsules: 150 mg (blue/red, marked R-150) 300 mg (red, marked R-300) Syrup: 100 mg/5 mL (red, raspberry flavoured) rifadin-ccdsv17-dsv20-20jun22 Page 2 IV infusion: 600 mg (spongy, fragile amorphous red powder), with 10 mL sterile water for injection solvent 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Tuberculosis Rifampicin is indicated in the treatment of all forms of tuberculosis, including fresh, advanced, chronic and drug resistant cases. Rifampicin should be used in conjunction with at least one other antituberculosis medicine. Leprosy Rifampicin is indicated in the treatment of multibacillary and paucibacillary leprosy to effect a conversion of the infectious state to a non-infectious state. Rifampicin should be used in conjunction with at least one other anti-leprosy drug. Methicillin-resistant Staphylococcal infections (MRSA) Rifampicin can be used as an alternative to vancomycin in the treatment of MRSA. In such circumstances an appropriate companion antibiotic (e.g. fusidic acid) should always be employed. Serious Staphylococcal Infections Rifampicin has been used for the treatment of both life-threatening and serious staphylococcal infections. In such circumstances an appropriate companion antibiotic should be employed (see Section 4.2). Brucellosis Rifam Read the complete document